Amanda Psyrri - Concepedia

Author

Amanda Psyrri

National and Kapodistrian University of Athens ORCID

Also Known As

A Psyrri, A. Psyrri, AMANDA PSYRRI, Amanda K. Psyrri, Amanda Psyrri, Christos Papadimitriou, Katharine A. Price, Psyrri, Amanda

601

Publications

18.2K

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens University General Hospital Attikon Yale University Aristotle University of Thessaloniki Papageorgiou General Hospital

About

Amanda Psyrri is an author at National and Kapodistrian University of Athens specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	44	8.3K
2	Health Sciences	12	13	954
3	Cell Biology	10	10	328
4	Public Health	1	1	16
5	Cellular Physiology	1	1	14

Amanda Psyrri

130

Publications

10.8K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study Barbara Burtness, Kevin J. Harrington, Richard Greil, The Lancet Neoadjuvant TherapyChemotherapy Versus CetuximabMedicinePathologyHead And Neck Cancer	2019	3K
Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis Paul Weinberger, Ziwei Yu, Bruce G. Haffty, Journal of Clinical Oncology	2006	796
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri, The Lancet Oncology Neoadjuvant TherapySquamous Cell CarcinomaMedicineHead And Neck CancerCancer Treatment	2021	582
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study Kevin J. Harrington, Barbara Burtness, Richard Greil, Journal of Clinical Oncology	2022	438
Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis Amanda Psyrri, Ziwei Yu, Paul Weinberger, Clinical Cancer Research	2005	265
Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C. David J. Adelstein, John A. Ridge, Maura L. Gillison, Head & Neck Tumor BiologyHuman PapillomavirusHuman Papillomavirus VaccinesMedicineNasopharyngeal Cancer	2009	261
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial Jan B. Vermorken, Amanda Psyrri, Frédéric Peyrade, Annals of Oncology	2014	207
Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Maria Vassilakopoulou, Margaritis Avgeris, Vamsidhar Velcheti, Clinical Cancer Research	2015	206
Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma George Koutsodontis, George Papaxoinis, Ilias Angelidis, Annals of Oncology	2017	186
Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer Paul Weinberger, Ziwei Yu, Bruce G. Haffty, Clinical Cancer Research	2004	153

Page 1